Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Zoledronic acid is a medication that slows the breakdown of bone. This study will assess the
efficacy and safety of zoledronic acid in Chinese patients with multiple myeloma or other
solid tumors with bone metastases.